Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis

被引：0

作者：

Castilla, J. ^{[1
,2
,3
]}

Martinez-Baz, I. ^{[1
,2
,3
]}

Martinez-Artola, V. ^{[4
]}

Fernandez-Alonso, M. ^{[5
]}

Reina, G. ^{[5
]}

Guevara, M. ^{[1
,2
,3
]}

Garcia Cenoz, M. ^{[1
,2
,3
]}

Elia, F. ^{[6
]}

Alvarez, N. ^{[7
]}

Barricarte, A. ^{[1
,2
,3
]}

Ezpeleta, C. ^{[4
]}

机构：

[1] Publ Hlth Inst Navarre, Pamplona, Spain

[2] Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Network Biomed Res, Ctr Epidemiol, Barcelona, Spain

[3] Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Network Biomed Res, Ctr Publ Hlth, Barcelona, Spain

[4] Hosp Complex Navarre, Pamplona, Spain

[5] Univ Navarra Clin, Pamplona, Spain

[6] Navarre Hlth Serv, Primary Healthcare Directorate, Pamplona, Spain

[7] Navarre Hlth Serv, Pamplona, Spain

来源：

EUROSURVEILLANCE | 2013年 / 18卷 / 07期

关键词：

D O I：

暂无

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

We present estimates of influenza vaccine effectiveness (VE) in Navarre, Spain, in the early 2012/13 season, which was dominated by influenza B. In a population-based cohort using electronic records from physicians, the adjusted VE in preventing influenza-like illness was 32% (95% confidence interval (CI): 15 to 46). In a nested test-negative case-control analysis the adjusted VE in preventing laboratory-confirmed influenza was 86% (95% CI: 45 to 96). These results suggest a high protective effect of the vaccine.

引用

页码：6 / 11

页数：6

共 14 条

[1]

Aguilar I, 2012, EURO SURVEILL, V17

[2]

[Anonymous], 2012, Wkly Epidemiol Rec, V87, P83

[3]

[Anonymous], EURO SURVEILL

[4]

[Anonymous], EURO SURVEILL

[5]

[Anonymous], EURO SURVEILL

[6]

[Anonymous], 2013, 52013 I SAL CARL 3

[7]

European Commission, 2008, OFFICIAL J EUROPEAN, VL 159

[8]

Instituto de Salud Publica de Navarra, 2012, B INF, V69

[9] Evidence of bias in estimates of influenza vaccine effectiveness in seniors [J].

Jackson, LA ;

Jackson, ML ;

Nelson, JC ;

Neuzil, KM ;

Weiss, NS .

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2006, 35 (02) :337-344

[10]

Jackson L, 2013, MMWR-MORBID MORTAL W, V62, P32

← 1 2 →